{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Rank</th>\n",
       "      <th>NCT_Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study_Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome_Measures</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funded_Bys</th>\n",
       "      <th>Study_Type</th>\n",
       "      <th>Start_Date</th>\n",
       "      <th>Completion_Date</th>\n",
       "      <th>First_Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>p-values</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>NCT04425538</td>\n",
       "      <td>A Phase 2 Trial of Infliximab in Coronavirus D...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Infliximab</td>\n",
       "      <td>Time to improvement in oxygenation|28-day mort...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>17</td>\n",
       "      <td>Other|NIH</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>6/1/2020</td>\n",
       "      <td>1/22/2021</td>\n",
       "      <td>6/11/2020</td>\n",
       "      <td>United States</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>NCT04452435</td>\n",
       "      <td>Safety and Efficacy of C21 in Subjects With CO...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: C21|Drug: Placebo</td>\n",
       "      <td>Change From Baseline in C-reactive Protein (CR...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 70 Years   (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>206</td>\n",
       "      <td>Industry|Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>7/21/2020</td>\n",
       "      <td>10/13/2020</td>\n",
       "      <td>6/30/2020</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>0.4891</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>NCT04445272</td>\n",
       "      <td>Clinical Trial to Evaluate the Effectiveness a...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Tocilizumab</td>\n",
       "      <td>To calulate the time of intubation|To calculat...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>495</td>\n",
       "      <td>Other|Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>5/22/2020</td>\n",
       "      <td>12/23/2020</td>\n",
       "      <td>6/24/2020</td>\n",
       "      <td>Spain</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4</td>\n",
       "      <td>NCT04355741</td>\n",
       "      <td>Gut Microbiota, \"Spark and Flame\" of COVID-19 ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Other: Exposure</td>\n",
       "      <td>Differences in gut microbiota composition betw...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>115</td>\n",
       "      <td>Other</td>\n",
       "      <td>Observational</td>\n",
       "      <td>4/20/2020</td>\n",
       "      <td>7/16/2020</td>\n",
       "      <td>4/21/2020</td>\n",
       "      <td>Portugal</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5</td>\n",
       "      <td>NCT04578158</td>\n",
       "      <td>Trial to Study the Adjuvant Benefits of Querce...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Standard COVID-19 care|Dietary Supplemen...</td>\n",
       "      <td>Percentage of subjects with COVID-19 disease p...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>152</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>9/29/2020</td>\n",
       "      <td>4/15/2021</td>\n",
       "      <td>10/8/2020</td>\n",
       "      <td>Pakistan</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Rank   NCT_Number                                              Title  \\\n",
       "0     1  NCT04425538  A Phase 2 Trial of Infliximab in Coronavirus D...   \n",
       "1     2  NCT04452435  Safety and Efficacy of C21 in Subjects With CO...   \n",
       "2     3  NCT04445272  Clinical Trial to Evaluate the Effectiveness a...   \n",
       "3     4  NCT04355741  Gut Microbiota, \"Spark and Flame\" of COVID-19 ...   \n",
       "4     5  NCT04578158  Trial to Study the Adjuvant Benefits of Querce...   \n",
       "\n",
       "      Status         Study_Results Conditions  \\\n",
       "0  Completed  No Results Available   COVID-19   \n",
       "1  Completed           Has Results   COVID-19   \n",
       "2  Completed  No Results Available   COVID-19   \n",
       "3  Completed  No Results Available   COVID-19   \n",
       "4  Completed  No Results Available   COVID-19   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0                                   Drug: Infliximab   \n",
       "1                            Drug: C21|Drug: Placebo   \n",
       "2                                  Drug: Tocilizumab   \n",
       "3                                    Other: Exposure   \n",
       "4  Drug: Standard COVID-19 care|Dietary Supplemen...   \n",
       "\n",
       "                                    Outcome_Measures Gender  \\\n",
       "0  Time to improvement in oxygenation|28-day mort...    All   \n",
       "1  Change From Baseline in C-reactive Protein (CR...    All   \n",
       "2  To calulate the time of intubation|To calculat...    All   \n",
       "3  Differences in gut microbiota composition betw...    All   \n",
       "4  Percentage of subjects with COVID-19 disease p...    All   \n",
       "\n",
       "                                           Age   Phases  Enrollment  \\\n",
       "0    18 Years and older   (Adult, Older Adult)  Phase 2          17   \n",
       "1  18 Years to 70 Years   (Adult, Older Adult)  Phase 2         206   \n",
       "2    18 Years and older   (Adult, Older Adult)  Phase 2         495   \n",
       "3    18 Years and older   (Adult, Older Adult)      NaN         115   \n",
       "4    18 Years and older   (Adult, Older Adult)  Phase 3         152   \n",
       "\n",
       "       Funded_Bys      Study_Type Start_Date Completion_Date First_Posted  \\\n",
       "0       Other|NIH  Interventional   6/1/2020       1/22/2021    6/11/2020   \n",
       "1  Industry|Other  Interventional  7/21/2020      10/13/2020    6/30/2020   \n",
       "2  Other|Industry  Interventional  5/22/2020      12/23/2020    6/24/2020   \n",
       "3           Other   Observational  4/20/2020       7/16/2020    4/21/2020   \n",
       "4           Other  Interventional  9/29/2020       4/15/2021    10/8/2020   \n",
       "\n",
       "         Locations p-values  \n",
       "0    United States      NaN  \n",
       "1   United Kingdom   0.4891  \n",
       "2            Spain      NaN  \n",
       "3         Portugal      NaN  \n",
       "4         Pakistan      NaN  "
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "import pandas as pd\n",
    "\n",
    "# File to Load (Remember to Change These)\n",
    "covid = \"covid-clinical-trial_data_cleandata.csv\"\n",
    "\n",
    "# Read Purchasing File and store into Pandas data frame\n",
    "covid_df = pd.read_csv(covid)\n",
    "covid_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Rank</th>\n",
       "      <th>NCT_Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study_Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome_Measures</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funded_Bys</th>\n",
       "      <th>Study_Type</th>\n",
       "      <th>Start_Date</th>\n",
       "      <th>Completion_Date</th>\n",
       "      <th>First_Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>p-values</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>43</td>\n",
       "      <td>NCT04331171</td>\n",
       "      <td>Epidemiological Observation From a Smartphone ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Device: Web application users</td>\n",
       "      <td>To assess of the evolution of the number of ca...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>12000000</td>\n",
       "      <td>Other|Industry</td>\n",
       "      <td>Observational</td>\n",
       "      <td>3/17/2020</td>\n",
       "      <td>11/15/2020</td>\n",
       "      <td>4/2/2020</td>\n",
       "      <td>France</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>259</th>\n",
       "      <td>260</td>\n",
       "      <td>NCT04460274</td>\n",
       "      <td>Forecast Number of Covid-19 Cases Worldwide</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Covid-19</td>\n",
       "      <td>Other: Model Building|Other: Model validation</td>\n",
       "      <td>Number of Confirmed cases of Covid-19</td>\n",
       "      <td>All</td>\n",
       "      <td>Child, Adult, Older Adult</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7882471</td>\n",
       "      <td>Other</td>\n",
       "      <td>Observational</td>\n",
       "      <td>12/31/2019</td>\n",
       "      <td>6/20/2020</td>\n",
       "      <td>7/7/2020</td>\n",
       "      <td>Turkey</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>792</th>\n",
       "      <td>793</td>\n",
       "      <td>NCT04407117</td>\n",
       "      <td>Appendicitis During the National Lockdown Duri...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Appendicitis</td>\n",
       "      <td>Behavioral: Lock-down and social distancing</td>\n",
       "      <td>Appendectomy|Postoperative length of stay|Mort...</td>\n",
       "      <td>All</td>\n",
       "      <td>Child, Adult, Older Adult</td>\n",
       "      <td>NaN</td>\n",
       "      <td>6000000</td>\n",
       "      <td>Other</td>\n",
       "      <td>Observational</td>\n",
       "      <td>3/23/2017</td>\n",
       "      <td>4/19/2020</td>\n",
       "      <td>5/29/2020</td>\n",
       "      <td>Denmark</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>890</th>\n",
       "      <td>891</td>\n",
       "      <td>NCT04891276</td>\n",
       "      <td>Impact of COVID-19 Infection and Confinement o...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Diabetic Subjects With Hospital Stays</td>\n",
       "      <td>Other: Data collection</td>\n",
       "      <td>Frequency of lower limb amputations</td>\n",
       "      <td>All</td>\n",
       "      <td>Child, Adult, Older Adult</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3300000</td>\n",
       "      <td>Other</td>\n",
       "      <td>Observational</td>\n",
       "      <td>10/16/2020</td>\n",
       "      <td>4/14/2021</td>\n",
       "      <td>5/18/2021</td>\n",
       "      <td>France</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     Rank   NCT_Number                                              Title  \\\n",
       "42     43  NCT04331171  Epidemiological Observation From a Smartphone ...   \n",
       "259   260  NCT04460274        Forecast Number of Covid-19 Cases Worldwide   \n",
       "792   793  NCT04407117  Appendicitis During the National Lockdown Duri...   \n",
       "890   891  NCT04891276  Impact of COVID-19 Infection and Confinement o...   \n",
       "\n",
       "        Status         Study_Results                             Conditions  \\\n",
       "42   Completed  No Results Available                               COVID-19   \n",
       "259  Completed  No Results Available                               Covid-19   \n",
       "792  Completed  No Results Available                           Appendicitis   \n",
       "890  Completed  No Results Available  Diabetic Subjects With Hospital Stays   \n",
       "\n",
       "                                     Interventions  \\\n",
       "42                   Device: Web application users   \n",
       "259  Other: Model Building|Other: Model validation   \n",
       "792    Behavioral: Lock-down and social distancing   \n",
       "890                         Other: Data collection   \n",
       "\n",
       "                                      Outcome_Measures Gender  \\\n",
       "42   To assess of the evolution of the number of ca...    All   \n",
       "259              Number of Confirmed cases of Covid-19    All   \n",
       "792  Appendectomy|Postoperative length of stay|Mort...    All   \n",
       "890                Frequency of lower limb amputations    All   \n",
       "\n",
       "                                           Age Phases  Enrollment  \\\n",
       "42   18 Years and older   (Adult, Older Adult)    NaN    12000000   \n",
       "259                  Child, Adult, Older Adult    NaN     7882471   \n",
       "792                  Child, Adult, Older Adult    NaN     6000000   \n",
       "890                  Child, Adult, Older Adult    NaN     3300000   \n",
       "\n",
       "         Funded_Bys     Study_Type  Start_Date Completion_Date First_Posted  \\\n",
       "42   Other|Industry  Observational   3/17/2020      11/15/2020     4/2/2020   \n",
       "259           Other  Observational  12/31/2019       6/20/2020     7/7/2020   \n",
       "792           Other  Observational   3/23/2017       4/19/2020    5/29/2020   \n",
       "890           Other  Observational  10/16/2020       4/14/2021    5/18/2021   \n",
       "\n",
       "    Locations p-values  \n",
       "42     France      NaN  \n",
       "259    Turkey      NaN  \n",
       "792   Denmark      NaN  \n",
       "890    France      NaN  "
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Most popular clinical trials by enrollment\n",
    "import numpy as np\n",
    "enrollment_sort= covid_df.sort_values(by='Enrollment', ascending=False)\n",
    "total_enrolled = enrollment_sort['Enrollment'].sum()\n",
    "top_enrollment = enrollment_sort.head(4)\n",
    "top_total = top_enrollment['Enrollment'].sum()\n",
    "remaining = total_enrolled - top_total\n",
    "top_enrollment"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Pie chart of most popular trial enrollment distribution \n",
    "values_enrollment = np.append(top_enrollment['Enrollment'].to_numpy(), remaining)\n",
    "labels_enrollment = np.append(top_enrollment['Title'].to_numpy(), 'Rest of trials')\n",
    "fig_enrollment, ax_enrollment = plt.subplots()\n",
    "\n",
    "def fmt(x):\n",
    "    return '{:.0f}\\n({:.2f}%)'.format(total_enrolled*x/100, x)\n",
    "    \n",
    "ax_enrollment.pie(values_enrollment, labels=labels_enrollment, autopct=fmt)\n",
    "plt.title(f'Enrollment distribution of top 4 trials.  Total enrollment: {total_enrolled}')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Percentage of all trials that 'have results' coming from the rest of trials: 100.0%\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Rank</th>\n",
       "      <th>NCT_Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study_Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome_Measures</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funded_Bys</th>\n",
       "      <th>Study_Type</th>\n",
       "      <th>Start_Date</th>\n",
       "      <th>Completion_Date</th>\n",
       "      <th>First_Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>p-values</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>790</th>\n",
       "      <td>791</td>\n",
       "      <td>NCT04385238</td>\n",
       "      <td>Health and Wellbeing of Pregnant and Post-Part...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>COVID-19|Pregnancy Complications|Mental Health...</td>\n",
       "      <td>Other: This is an online survey with no interv...</td>\n",
       "      <td>Number of Participants With Symptoms of Post-t...</td>\n",
       "      <td>Female</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>6894</td>\n",
       "      <td>Industry|Other</td>\n",
       "      <td>Observational</td>\n",
       "      <td>5/15/2020</td>\n",
       "      <td>6/20/2020</td>\n",
       "      <td>5/12/2020</td>\n",
       "      <td>United States</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>118</th>\n",
       "      <td>119</td>\n",
       "      <td>NCT04292899</td>\n",
       "      <td>Study to Evaluate the Safety and Antiviral Act...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Remdesivir|Drug: Standard of Care</td>\n",
       "      <td>Part A: Percentage of Participants in Each Cli...</td>\n",
       "      <td>All</td>\n",
       "      <td>12 Years and older   (Child, Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>4891</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>3/6/2020</td>\n",
       "      <td>6/30/2020</td>\n",
       "      <td>3/3/2020</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>0.1563</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1067</th>\n",
       "      <td>1068</td>\n",
       "      <td>NCT04634903</td>\n",
       "      <td>Testing Scalable, Single-Session Interventions...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Depression</td>\n",
       "      <td>Behavioral: Supportive Therapy SSI|Behavioral:...</td>\n",
       "      <td>Change in Adolescent Depressive Symptom Severi...</td>\n",
       "      <td>All</td>\n",
       "      <td>13 Years to 16 Years   (Child)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>2452</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>11/19/2020</td>\n",
       "      <td>3/15/2021</td>\n",
       "      <td>11/18/2020</td>\n",
       "      <td>United States</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1035</th>\n",
       "      <td>1036</td>\n",
       "      <td>NCT04308668</td>\n",
       "      <td>Post-exposure Prophylaxis / Preemptive Therapy...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Corona Virus Infection|Acute Respiratory Distr...</td>\n",
       "      <td>Drug: Hydroxychloroquine|Other: Placebo</td>\n",
       "      <td>Number of Participants With Active COVID-19 Di...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>1312</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>3/17/2020</td>\n",
       "      <td>5/20/2020</td>\n",
       "      <td>3/16/2020</td>\n",
       "      <td>Canada</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123</th>\n",
       "      <td>124</td>\n",
       "      <td>NCT04292730</td>\n",
       "      <td>Study to Evaluate the Safety and Antiviral Act...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Remdesivir|Drug: Standard of Care</td>\n",
       "      <td>Part A: Percentage of Participants in Each Cli...</td>\n",
       "      <td>All</td>\n",
       "      <td>12 Years and older   (Child, Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>1113</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>3/15/2020</td>\n",
       "      <td>6/26/2020</td>\n",
       "      <td>3/3/2020</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>0.0174</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "      Rank   NCT_Number                                              Title  \\\n",
       "790    791  NCT04385238  Health and Wellbeing of Pregnant and Post-Part...   \n",
       "118    119  NCT04292899  Study to Evaluate the Safety and Antiviral Act...   \n",
       "1067  1068  NCT04634903  Testing Scalable, Single-Session Interventions...   \n",
       "1035  1036  NCT04308668  Post-exposure Prophylaxis / Preemptive Therapy...   \n",
       "123    124  NCT04292730  Study to Evaluate the Safety and Antiviral Act...   \n",
       "\n",
       "         Status Study_Results  \\\n",
       "790   Completed   Has Results   \n",
       "118   Completed   Has Results   \n",
       "1067  Completed   Has Results   \n",
       "1035  Completed   Has Results   \n",
       "123   Completed   Has Results   \n",
       "\n",
       "                                             Conditions  \\\n",
       "790   COVID-19|Pregnancy Complications|Mental Health...   \n",
       "118                                            COVID-19   \n",
       "1067                                         Depression   \n",
       "1035  Corona Virus Infection|Acute Respiratory Distr...   \n",
       "123                                            COVID-19   \n",
       "\n",
       "                                          Interventions  \\\n",
       "790   Other: This is an online survey with no interv...   \n",
       "118             Drug: Remdesivir|Drug: Standard of Care   \n",
       "1067  Behavioral: Supportive Therapy SSI|Behavioral:...   \n",
       "1035            Drug: Hydroxychloroquine|Other: Placebo   \n",
       "123             Drug: Remdesivir|Drug: Standard of Care   \n",
       "\n",
       "                                       Outcome_Measures  Gender  \\\n",
       "790   Number of Participants With Symptoms of Post-t...  Female   \n",
       "118   Part A: Percentage of Participants in Each Cli...     All   \n",
       "1067  Change in Adolescent Depressive Symptom Severi...     All   \n",
       "1035  Number of Participants With Active COVID-19 Di...     All   \n",
       "123   Part A: Percentage of Participants in Each Cli...     All   \n",
       "\n",
       "                                                   Age          Phases  \\\n",
       "790          18 Years and older   (Adult, Older Adult)             NaN   \n",
       "118   12 Years and older   (Child, Adult, Older Adult)         Phase 3   \n",
       "1067                    13 Years to 16 Years   (Child)  Not Applicable   \n",
       "1035         18 Years and older   (Adult, Older Adult)         Phase 3   \n",
       "123   12 Years and older   (Child, Adult, Older Adult)         Phase 3   \n",
       "\n",
       "      Enrollment      Funded_Bys      Study_Type  Start_Date Completion_Date  \\\n",
       "790         6894  Industry|Other   Observational   5/15/2020       6/20/2020   \n",
       "118         4891        Industry  Interventional    3/6/2020       6/30/2020   \n",
       "1067        2452           Other  Interventional  11/19/2020       3/15/2021   \n",
       "1035        1312           Other  Interventional   3/17/2020       5/20/2020   \n",
       "123         1113        Industry  Interventional   3/15/2020       6/26/2020   \n",
       "\n",
       "     First_Posted        Locations p-values  \n",
       "790     5/12/2020    United States      NaN  \n",
       "118      3/3/2020   United Kingdom   0.1563  \n",
       "1067   11/18/2020    United States      NaN  \n",
       "1035    3/16/2020           Canada      NaN  \n",
       "123      3/3/2020   United Kingdom   0.0174  "
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Percentage of all 'has results' coming from trials other than the most popular above\n",
    "all_has_result = enrollment_sort[enrollment_sort['Study_Results'] == 'Has Results']\n",
    "rest_has_results = enrollment_sort.tail(-4)[enrollment_sort.tail(-4)['Study_Results'] == 'Has Results']\n",
    "print(f\"Percentage of all trials that 'have results' coming from the rest of trials: {(rest_has_results['Study_Results'].count()/all_has_result['Study_Results'].count()) * 100}%\")\n",
    "rest_has_results.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The mean participation is 27894\n",
      "The median participation is 150\n",
      "The std of enrollment is 474353\n"
     ]
    }
   ],
   "source": [
    "# Enrollment statistics\n",
    "enrollment = covid_df['Enrollment']\n",
    "enrollment_mean = '{:.0f}'.format(enrollment.mean())\n",
    "print(f\"The mean participation is {enrollment_mean}\")\n",
    "enrollment_med = '{:.0f}'.format(enrollment.median())\n",
    "print(f\"The median participation is {enrollment_med}\")\n",
    "enrollment_std = '{:.0f}'.format(enrollment.std())\n",
    "print(f\"The std of enrollment is {enrollment_std}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Enrollment with outliers removed\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "35     1033\n",
       "423    1024\n",
       "352    1017\n",
       "904    1011\n",
       "912    1011\n",
       "Name: Enrollment, dtype: int64"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Enrollment outliers\n",
    "lowerq = enrollment.quantile(0.25)\n",
    "upperq = enrollment.quantile(0.75)\n",
    "iqr = upperq - lowerq\n",
    "lower_bound = lowerq - 1.5*iqr\n",
    "upper_bound = upperq + 1.5*iqr\n",
    "enrollment_without_outliers = enrollment[(enrollment > lower_bound) & (enrollment < upper_bound)]\n",
    "print(\"Enrollment with outliers removed\")\n",
    "enrollment_without_outliers.sort_values(ascending=False).head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Text(0.04, 0.5, 'Number of trials')"
      ]
     },
     "execution_count": 56,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Histogram of enrollment numbers after removing outliers\n",
    "figure_enrollment_1, axes_enrollment_1 = plt.subplots()\n",
    "enrollment_without_outliers.hist(bins=10, ax=axes_enrollment_1)\n",
    "plt.suptitle('Distribution of number of trials vs. enrollment number', x=0.5, y=1.05, ha='center', fontsize='xx-large')\n",
    "figure_enrollment_1.text(0.5, 0.04, 'Enrollment number', ha='center')\n",
    "figure_enrollment_1.text(0.04, 0.5, 'Number of trials', va='center', rotation='vertical')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 82,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total enrollment (195894) without ouliers is much less than any one outlier\n"
     ]
    }
   ],
   "source": [
    "# The outliers of enrollment series lie very far away from rest of data\n",
    "print(f\"Total enrollment ({enrollment_without_outliers.sum()}) without ouliers is much less than any one outlier\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 85,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAYIAAAFUCAYAAAApnTu7AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAgAElEQVR4nO2debhVZdn/P18OIEdFUcCBQUEFFBHBEDEnNBEtw6lS1BwazMrUSgt9ncLMMbXUX2Vlr5nz8BI5oYlTmgoISqIYqeEBVBBQUWS8f3/c68DmuM/hwF57nXPWvj/Xta+z91rrPN/nWdP9DPdzPzIzgiAIgsqlVVNnIAiCIGhawhAEQRBUOGEIgiAIKpwwBEEQBBVOGIIgCIIKJwxBEARBhROGIMgVkhZJ2i75/r+Sft7I/3tC0rfq2ddDkklqnWZe00bSW5IObOp8BC2PMARBk5G8fBdI2iCtNM1sYzN7I630gqASCEMQNAmSegD7AAaMaNLMBEGFE4YgaCpOAJ4D/hc4sXajpCGS3pFUVbDtCEkvJ98HS/qnpIWS5ki6XlLbgmNN0g51xSRtJul+SXOTVsj9krrVOWx7SS9I+kDSXyVtXizjkjaV9MdEf5aknxfmt86xF0m6R9Kdkj6S9KKkXes5toukxYW6kgZKmiepjaTtJY2X9H6y7VZJHepJa41uMUlDJdXU0bo3OR9vSjq9YN9gSRMlfSjpXUlXF9MI8kMYgqCpOAG4NfkMl7QlgJk9B3wMHFBw7LHAbcn3FcAPgU7AnsAXgO81Qq8V8CdgW2AbYDFwfZE8fQPoAiwHfl1PWjcn+3cABgIHAUXHFxIOA+4GNk/KMUZSm7oHmdls4J/AUQWbjwXuMbNlgIBLk/ztBHQHLmpAtyiSWgF/A14CuuLn8ExJw5NDfgX8ysw2AbYH7lpXjaBlEYYgyBxJe+Mv5LvMbBLwH/yFV8vtwMjk2PbAF5NtmNkkM3vOzJab2VvA74D91qZpZu+b2b1m9omZfQRcUuT/bjGzf5nZx8D5wNfq1vQTg3UIcKaZfWxm7wHXAMc0ID/JzGpf5lcD7YAh9Rx7W0HZlaR7W1KGGWb2qJktMbO5SVprLXsRdgc6m9loM1uajKn8vqAMy4AdJHUys0WJcQ5yTBiCoCk4EXjEzOYlv2+joHso+X1kMoh8JPCimf0XQFLvpFvnHUkfAr/AWwcNImlDSb+T9N/k/54COtR50b9d8P2/QJsiaW+bbJ+TdE8txI3RFg3Ir0rXzFYCNUAXScclXk6LJD2UHHIPsKekLsC++BjK00kZtpB0R9Id9SHwl8aUvQjbJvoLC8pwLrBlsv+bQG/gNUkTJB26HhpBC6JZu8MF+UNSNfA1oErSO8nmDfCX8q5m9pKZTZP0X7zmXdgtBPAbYDIw0sw+knQm8JVGSP8Y6APsYWbvSBqQpKOCY7oXfN8GrxnPq7P9bWAJ0MnMljeu1Kv/P+mW6QbMNrOn8a6xVZjZQkmP4OdoJ+B2Wx0i+FLcMPQ3s/clHc5nu7dq+RjYsOD3VnXK8KaZ9Sr2j2b2b2BkktcjgXskdUxaSkEOiRZBkDWH4/38fYEByWcnvNZ7QsFxtwGn47Xiuwu2twc+BBZJ2hH4biN12+PjAguTwdgLixxzvKS+kjYERuN98ysKDzCzOcAjwC8lbSKpVTKI21AXzeckHZnMQzgTNyQNdbfchp+Lo1jTCLYHFiVl6Aqc3UAaU4AvStpc0laJbi0vAB9K+qmkaklVkvpJ2h1A0vGSOietl4XJ/6wgyC1hCIKsORH4k5nNNLN3aj94zfY4rZ60dTswFBhf0IUEcBbeSvgI79e+s5G61wLVeA3/OeDhIsfcgnsxvYP3459e5Bjwl3RbYBqwAO/O2boB7b8CRyfHfh04MhkvqI+xQC/gXTN7qWD7z4DdgA+AB4D7GkjjFnww+C3ccK06T4lx+zJuhN/Ez8kfgE2TQw4GXpG0CB84PsbMPm1AK2jhKBamCYLyIekiYAczO76p8xIE9REtgiAIggonDEEQBEGFE11DQRAEFU60CIIgCCqcMARBEAQVToubUNapUyfr0aNHU2cjCIKgRTFp0qR5Zta52L4WZwh69OjBxIkTmzobQRAELYpktn5RomsoCIKgwglDEARBUOGEIQiCIKhwWtwYQRBUGsuWLaOmpoZPP41wP8HaadeuHd26daNNm8+sfVQvYQiCoJlTU1ND+/bt6dGjB75WTRAUx8x4//33qampoWfPno3+v7J2DUk6WNJ0STMkjSqy/6RkzdQpyaeh5f6CoCL59NNP6dixYxiBYK1IomPHjuvceixbiyBZ+ekGYBi+ItMESWPNbFqdQ+80s9PKlY8gyANhBILGsj73SjlbBIOBGWb2hpktBe7AF/EOgiAImhHlNARdWXMN2JpkW12OkvSypHskdS+yPwiCJuSSSy5h5513pn///gwYMIDnn3++qbOUGtdeey2ffPLJWo+7++672Wmnndh///0BGDlyJP379+eaa64pmuaf//xnAObPn8+wYcPo1asXw4YNY8GCBUXTv/nmm+nVqxe9evXi5ptvXrV96NCh9OnThwEDBjBgwADee+89AK6//nr+9Kc/rXN568XMyvIBvgr8oeD314Hr6hzTEdgg+X4qvhpVsbROASYCE7fZZhsLgkpi2rRpTab97LPP2pAhQ+zTTz81M7O5c+farFmzmiw/abPtttva3Llz13rc8OHDbfz48WZmNmfOHKvvPbRs2TLbZZddbNmyZWZmdvbZZ9ull15qZmaXXnqp/eQnP/nM/7z//vvWs2dPe//9923+/PnWs2dPmz9/vpmZ7bfffjZhwoTP/M/HH39sAwYMqDe/xe4ZYKLV874up9dQDWsu+t0NmF3HCL1f8PP3wOXFEjKzG4EbAQYNGrRecbPHTJ7FleOmM3vhYrp0qObs4X04fGCxBkoQNGPOPBOmTEk3zQED4Npri+6aM2cOnTp1YoMNNgCgU6dOq/bVhnvp1KkTEydO5KyzzuKJJ55g0aJF/OAHP2DixIlI4sILL+Soo47i4Ycf5txzz2XFihV06tSJxx57jI8//pgf/OAHTJ06leXLl3PRRRdx2GGH8corr3DyySezdOlSVq5cyb333kuXLl342te+Rk1NDStWrOD888/n6KOPXiO/M2bM4NRTT2Xu3LlUVVVx99138/bbb3PVVVdx//33A3DaaacxaNAgPvzwQ2bPns3+++9Pp06dePzxx7n99tv5xS9+gZnxpS99icsvv5zRo0fzj3/8gzfffJMRI0Ywbtw43nvvPQYMGMB1113HPvvss0p//Pjx7LbbbrRu7a/Wv/71rzzxxBMAnHjiiQwdOpTLL1/zNTdu3DiGDRvG5ptvDsCwYcN4+OGHGTlyZL2XbMMNN6RHjx688MILDB48uDFXuUHKaQgmAL0k9QRmAcfga82uQtLW5ouBA4wAXi1HRsZMnsU5901l8TJff3vWwsWcc99UgDAGQdAABx10EKNHj6Z3794ceOCBHH300ey3334N/s/FF1/MpptuytSp/owtWLCAuXPn8u1vf5unnnqKnj17Mn/+fMC7nQ444ABuuukmFi5cyODBgznwwAP57W9/yxlnnMFxxx3H0qVLWbFiBQ8++CBdunThgQceAOCDDz74jPZxxx3HqFGjOOKII/j0009ZuXIlb7/99meOAzj99NO5+uqrefzxx+nUqROzZ8/mpz/9KZMmTWKzzTbjoIMOYsyYMVxwwQWMHz+eq666ikGDBvH973+fQw89lClFDPIzzzzD5z73uVW/3333Xbbe2pez3nrrrVd17RQya9YsundfXWfu1q0bs2bNWvX75JNPpqqqiqOOOorzzjtv1WDwoEGDePrpp5u3ITCz5ZJOA8YBVcBNZvaKpNF4E2UscLqkEcByYD5wUjnycuW46auMQC2Ll63gynHTwxAELYt6au7lYuONN2bSpEk8/fTTPP744xx99NFcdtllnHTSSfX+z9///nfuuOOOVb8322wz/va3v7Hvvvuu8m2vrf0+8sgjjB07lquuugpwV9mZM2ey5557cskll1BTU8ORRx5Jr1692GWXXTjrrLP46U9/yqGHHrpGTRzgo48+YtasWRxxxBGAT6xaFyZMmMDQoUPp3NkDdB533HE89dRTHH744Y1OY86cOey0007rpGtFFgerfdnfeuutdO3alY8++oijjjqKW265hRNOOAGALbbYgtdee22dtOqjrPMIzOxBM+ttZtub2SXJtgsSI4CZnWNmO5vZrma2v5mlU6o6zF64eJ22B0GwmqqqKoYOHcrPfvYzrr/+eu69914AWrduzcqVKwHW8Fs3s8+4MBbbVrv93nvvZcqUKUyZMoWZM2ey0047ceyxxzJ27Fiqq6sZPnw448ePp3fv3kyaNIlddtmFc845h9GjR38mrWIU5rNuXhvz/+tCdXX1GulvueWWzJnjnR5z5sxhiy22+Mz/dOvWbY1WS01NDV26dAGga1evqLZv355jjz2WF154YY1yVFdXl5xnqJBYQ106FD9Z9W0PgsCZPn06//73v1f9njJlCttuuy3gYwSTJk0CWGUcwLuTrr/++lW/FyxYwJ577smTTz7Jm2++CbCqa2j48OFcd911q17CkydPBuCNN95gu+224/TTT2fEiBG8/PLLzJ49mw033JDjjz+es846ixdffHGNvG6yySZ069aNMWPGALBkyRI++eQTtt12W6ZNm8aSJUv44IMPeOyxx1b9T/v27fnoo48A2GOPPXjyySeZN28eK1as4Pbbb19rN1hddtppJ2bMmLHq94gRI1Z5Ad18880cdthnPeiHDx/OI488woIFC1iwYAGPPPIIw4cPZ/ny5cybNw/wMCP3338//fr1W/V/r7/++hq/S6EiDMHZw/tQ3aZqjW3Vbao4e3ifJspRELQMFi1axIknnkjfvn3p378/06ZN46KLLgLgwgsv5IwzzmCfffahqmr183XeeeexYMEC+vXrx6677srjjz9O586dufHGGznyyCPZddddVw3ynn/++Sxbtoz+/fvTr18/zj//fADuvPNO+vXrx4ABA3jttdc44YQTmDp1KoMHD2bAgAFccsklnHfeeZ/J7y233MKvf/1r+vfvz+c//3neeecdunfvzte+9jX69+/Pcccdx8CBA1cdf8opp3DIIYew//77s/XWW3PppZey//77s+uuu7LbbrsVfXE3xCGHHMJTTz216veoUaN49NFH6dWrF48++iijRnmAhYkTJ/Ktb3kghc0335zzzz+f3Xffnd13350LLriAzTffnCVLljB8+PBVbrtdu3bl29/+9qq0n3nmGQ488MB1yl99tLjF6wcNGmTrszBNeA0FLZVXX311nfudg6bjiCOO4IorrqBXr15l05g8eTJXX301t9xyS9H9xe4ZSZPMbFCx4ysm6NzhA7vGiz8IgrJz2WWXMWfOnLIagnnz5nHxxRenll7FGIIgCIIs6NOnD336lLfbediwYammVxFjBEHQ0mlpXbhB07E+90oYgiBo5rRr1473338/jEGwVixZj2Bd51BE11AQNHO6detGTU0Nc+fObeqsBC2A2hXK1oUwBEHQzGnTps06rTYVBOtKdA0FQRBUOGEIgiAIKpwwBEEQBBVOGIIgCIIKJwxBEARBhROGIAiCoMIJQxAEQVDhhCEIgiCocMIQBEEQVDhhCIIgCCqcMARBEAQVThiCIAiCCicMQRAEQYUThiAIgqDCCUMQBEFQ4YQhCIIgqHDCEARBEFQ4YQiCIAgqnDAEQRAEFU4YgiAIggqnrIZA0sGSpkuaIWlUA8d9RZJJGlTO/ARBEASfpWyGQFIVcANwCNAXGCmpb5Hj2gOnA8+XKy9BEARB/ZSzRTAYmGFmb5jZUuAO4LAix10MXAF8Wsa8BEEQBPVQTkPQFXi74HdNsm0VkgYC3c3s/jLmIwiCIGiAchoCFdlmq3ZKrYBrgB+vNSHpFEkTJU2cO3duilkMgiAIymkIaoDuBb+7AbMLfrcH+gFPSHoLGAKMLTZgbGY3mtkgMxvUuXPnMmY5CIKg8iinIZgA9JLUU1Jb4BhgbO1OM/vAzDqZWQ8z6wE8B4wws4llzFMQBEFQh7IZAjNbDpwGjANeBe4ys1ckjZY0oly6QRAEwbrRupyJm9mDwIN1tl1Qz7FDy5mXIAiCoDgxszgIgqDCCUMQBEFQ4YQhCIIgqHDCEARBEFQ4YQiCIAgqnDAEQRAEFU4YgiAIggonDEEQBEGFE4YgCIKgwglDEARBUOGEIQiCIKhwwhAEQRBUOGEIgiAIKpwwBEEQBBVOGIIgCIIKJwxBEARBhROGIAiCoMIJQxAEQVDhhCEIgiCocMIQBEEQVDhhCIIgCCqcMARBEAQVThiCIAiCCicMQRAEQYUThiAIgqDCCUMQBEFQ4YQhCIIgqHDCEARBEFQ4YQiCIAgqnDAEQRAEFU5ZDYGkgyVNlzRD0qgi+0+VNFXSFEn/kNS3nPkJgiAIPkvZDIGkKuAG4BCgLzCyyIv+NjPbxcwGAFcAV5crP0EQBEFxytkiGAzMMLM3zGwpcAdwWOEBZvZhwc+NACtjfoIgCIIitC5j2l2Btwt+1wB71D1I0veBHwFtgQOKJSTpFOAUgG222Sb1jAZBEFQy5WwRqMi2z9T4zewGM9se+ClwXrGEzOxGMxtkZoM6d+6ccjaDPDNm8iz2umw8PUc9wF6XjWfM5FlNnaUgaHaUs0VQA3Qv+N0NmN3A8XcAvyljfoIKY8zkWZxz31QWL1sBwKyFiznnvqkAHD6wa1NmLQiaFeVsEUwAeknqKaktcAwwtvAASb0Kfn4J+HcZ8xNUGFeOm77KCNSyeNkKrhw3vYlyFATNk7K1CMxsuaTTgHFAFXCTmb0iaTQw0czGAqdJOhBYBiwATixXfoLKY/bCxeu0PQgqlXJ2DWFmDwIP1tl2QcH3M8qpH1Q2XTpUM6vIS79Lh+omyE0QNF8a1TUkaUNJ50v6ffK7l6RDy5u1ICiNs4f3obpN1RrbqttUcfbwPk2UoyBonjR2jOBPwBJgz+R3DfDzsuQoCFLi8IFdufTIXejaoRoBXTtUc+mRu8RAcRDUobFdQ9ub2dGSRgKY2WJJxdxDg6BZcfjArvHiD4K10NgWwVJJ1STzACRtj7cQgiAIghZOY1sEFwIPA90l3QrsBZxUrkwFQRAE2dEoQ2Bmj0p6ERiCzxg+w8zmlTVnQRAEQSY0yhBI2jf5+lHyt68kzOyp8mQrCIIgyIrGdg2dXfC9HR5ZdBL1BIkLgiAIWg6N7Rr6cuFvSd3x9QOCIAiCFs76xhqqAfqlmZEgCIKgaWjsGMF1rA4h3QoYALxUrkwFQRAE2dHYMYKJBd+XA7eb2TNlyE8QBEGQMY0dI7i53BkJgiAImoYGDYGkqRRfR1iAmVn/suQqCIIgyIy1tQgiwmgQBEHOadAQmNl/s8pIEARB0DQ0dj2CIZImSFokaamkFZI+LHfmgiAIgvLT2HkE1wMj8TWFq4FvAdeVK1NBEARBdjR6qUozmyGpysxWAH+S9GwZ8xUEQRBkRGMNwSeS2gJTJF0BzAE2Kl+2giAIgqxobNfQ15NjTwM+BroDR5UrU0EQBEF2NLZFsBvwoJl9CPysjPkJgiAIMqaxLYIRwOuSbpH0JUmNHlsIgiAImjeNMgRmdjKwA3A3cCzwH0l/KGfGgiAIgmxYF6+hZZIewkNOVAOH4W6kQRAEQQumsRPKDpb0v8AM4CvAH4Cty5ivIAiCICMa2yI4CbgD+I6ZLSlfdoIgCIKsaWwY6mNqv0s61MzuL1+WgiAIgixZn6UqR6eeiyAIgqDJWB9DoEYf6GML0yXNkDSqyP4fSZom6WVJj0nadj3yEwRBEJRAYweL2yUv7fuABZJ+KKndWv6nCrgBOAToC4yU1LfOYZOBQckCN/cAV6xzCYIgCIKSaGyL4M/AznjE0YuBnYBb1vI/g4EZZvaGmS3FB5sPKzzAzB43s0+Sn88B3Rqb8SAIgiAdGus11MfMdi34/bikl9byP12Btwt+1wB7NHD8N4GHiu2QdApwCsA222yz9twGQRAEjaaxLYLJkobU/pC0B/DMWv6n2FhCsfWPkXQ8MAi4sth+M7vRzAaZ2aDOnTs3MstBEARBY2hsi2AP4ARJM5Pf2wCv1i5uX88i9jV4lNJaugGz6x4k6UDgf4D9Yo5CEARB9jTWEBy8HmlPAHpJ6gnMAo7B4xStQtJA4HfAwWb23npoBEEQBCXS2All67yIvZktl3QaMA6oAm4ys1ckjQYmmtlYvCtoY+BuSQAzzWzEumoFQRAE609Zw0mb2YPAg3W2XVDw/cBy6gdBEARrZ30mlAVBEAQ5IgxBEARBhROGIAiCoMIJQxAEQVDhhCEIgiCocMIQBEEQVDhhCIIgCCqcMARBEAQVTlknlAVBJTBm8iyuHDed2QsX06VDNWcP78PhA7s2dbaCoNGEIQiCEhgzeRbn3DeVxctWADBr4WLOuW8qQBiDoMUQXUNBUAJXjpu+ygjUsnjZCq4cN72JchQE604YgiAogdkLF6/T9iBojoQhCIIS6NKhep22B0FzJAxBEJTA2cP7UN2mao1t1W2qOHt4nybKURCsOzFYHAQlUDsgHF5DQUsmDEEQlMjhA7vGiz9o0UTXUBAEQYUThiAIgqDCCUMQBEFQ4YQhCIIgqHDCEARBEFQ4YQiCIAgqnDAEQRAEFU4YgiAIggonDEEQBEGFE4YgCIKgwglDEARBUOGEIQiCIKhwwhAEQRBUOGU1BJIOljRd0gxJo4rs31fSi5KWS/pKOfMSBEEQFKdshkBSFXADcAjQFxgpqW+dw2YCJwG3lSsfQRAEQcOUcz2CwcAMM3sDQNIdwGHAtNoDzOytZN/KMuYjCIIgaIBydg11Bd4u+F2TbAuCIAiaEeU0BCqyzdYrIekUSRMlTZw7d26J2QqCIAgKKachqAG6F/zuBsxen4TM7EYzG2Rmgzp37pxK5oIgCAKnnIZgAtBLUk9JbYFjgLFl1AuCIAjWg7IZAjNbDpwGjANeBe4ys1ckjZY0AkDS7pJqgK8Cv5P0SrnyEwRBEBSnnF5DmNmDwIN1tl1Q8H0C3mUUBEEQNBExszgIgqDCCUMQBEFQ4YQhCIIgqHDCEARBEFQ4YQiCIAgqnDAEQRAEFU4YgiAIggonDEEQBEGFE4YgCIKgwglDEARBUOGEIQiCIKhwyhprKAiCoC5jJs/iynHTmb1wMV06VHP28D4cPjDWrGpKwhAEnyEe1KBcjJk8i3Pum8riZSsAmLVwMefcNxUg7rEmpLIMwZlnwpQpTZ2LZs28RUvoMvdjfmmrF5Nr9Rsxr/NGdNp4gybMWZAHtpm5kD8tX/GZ7W1vrYJtOjRBjloQAwbAtdeWJekYIwjWYOb8xay0NVcUXWnGzPmLmyhHQZ5YWsQINLQ9yIbKahGUyZrmiaNGPVB0YWkBb172payzE+SMH182nlkLP1up6NqhmmdGHdAEOQogWgQtjjGTZ7HXZePpOeoB9rpsPGMmz0o1/S4dqtdpexCsC2cP70N1m6o1tlW3qeLs4X2aKEcBhCFoUdQOtM1auBhj9UBbmsYgHtSgnBw+sCuXHrkLXTtUI7wlcOmRu8RAcRNTWV1DZabc3jZXjpu+ytuilsXLVnDluOmp6dSmE15DQbk4fGDXuJ+aGWEIUiILt7jZRfpWG9q+vsSDGgSVRXQNpURDtfW0iP77IAjKQRiClMiith7990HQvCi380ZWRNdQSnTpUF3ULS7N2nr03wdB8yFPs6TDEKTE2cP7rHFTQHlq69F/X7lE6I/mRRbOG1kRhiAlorYelJM81T7zQlbOG1kQhiBForYelIs81T7zQhbdwVkRg8VB0ALIU+0zL+TJeSMMQRC0AMJ1uPmRp1nS0TUUBC2ArJwRgnUjL93BZW0RSDpY0nRJMySNKrJ/A0l3Jvufl9SjnPkJgpZKnmqfQfOjbC0CSVXADcAwoAaYIGmsmU0rOOybwAIz20HSMcDlwNHlylPQvAh3yHUji9pnnq5JXsqSRTnK2TU0GJhhZm8ASLoDOAwoNASHARcl3+8BrpckMysWEj/IEeEO2fzI0zXJS1myKkc5u4a6Am8X/K5JthU9xsyWAx8AHcuYp6CZkEVspmDdyNM1yUtZsipHOQ2BimyrW9NvzDFIOkXSREkT586dm0rmgqYl3CGbH3m6JnkpS1blKKchqAG6F/zuBsyu7xhJrYFNgfl1EzKzG81skJkN6ty5c5myG2RJuEM2P/J0TfJSlqzKUU5DMAHoJamnpLbAMcDYOseMBU5Mvn8FGB/jA5VBnibj5IU8XZO8lCWrcpRtsNjMlks6DRgHVAE3mdkrkkYDE81sLPBH4BZJM/CWwDHlyk/QvIjYTM2PPF2TvJQlq3KopVXABw0aZBMnTmzqbARBELQoJE0ys0HF9kWIiSAIggonDEEQBEGFE4YgCIKgwglDEARBUOGEIQiCIKhwwhAEQRBUOGEIgiAIKpwwBEEQBBVOGIIgCIIKJwxBEARBhdPiQkxImgv8t4QkOgHzUspOaLQcnbxoZKWTF42sdFqCxrZmVjR8c4szBKUiaWJ98TZCI3uNrHTyopGVTl40stJp6RrRNRQEQVDhhCEIgiCocCrRENwYGs1KIyudvGhkpZMXjax0WrRGxY0RBEEQBGtSiS2CIAiCoIAwBEEQBBVOGIIgCIIKJwxBjpCkLDQktcpCK23q5jkpRybPQFbnqyVel6Yii/s4TY1y5rXiDIGkzZtYP7WLKWkTSe0lVQGYmUnqmlb6BTo7SNpcUpU5Ky1lL4MsrktyfraW1CH5vdLMVqatI2mX5JxtJ2nLWu0y6AyQ1Dv5bFUunXKT3Mftku9le9lJ6iWpo6Q2sOr6p30f7yxp09rfaWok9++XJW1UR3N7Sa1LSbuivIYkVQMXmtmogt+nAx2Bh8zs8RS1OgJLgE/qvmwkbW9m/ykx/Q2Be4CHgAX41PN5wCjgB8ACM/u0RI02wEnAvsCXgHbAM8B/gN+Y2UulpF+gU/brkjwohwN7A8OAzYHXgaeB35nZ2xD4NFYAACAASURBVClotAXOAPYBegPbAg8CHwB/NrMnStUo0PkJXo7NgPeAj4H5+P1wTxoGLmktWbEXmaRtzGxmCul/ATgIWAncamYvS2plZislbWZmC0rRSHTaAKcABwJ74tfjPWAGcJuZPZqCRlvg+8BwvCzfSDS3B+7Hr0lJL1tJGwOTgN3M7GNJRwI/Al7Cy/Pr9T1fldYi2BW/EZDUHbgB6AGsAL4tqVcaIpL6Av8POBkYKekgSYMkdZE0EBifgsxmwHbAocBQ4FjgPPyF/U3g+BQ0dsPLcJKZbQ5cCryF33QnJ8YuDbK4LgOAHwK/xV+g9wBT8GfglLq1rPXkc8DhZjbCzHbEjcIiYDpwvKRtUtAA2AP4qpntZ2b9ga8Bv0h0RgL7lSogqTfwa/z+3Sdp4XROuga3Be4qVQPoD1wIvINXYv5X0mGJEdg62ZcGuwPfAb5hZlvhhvpCYA5+XXZLQWMA8FXg68CjeAXgQ6AGOAEYnILGLsDcxAjsjFf4LsSN/0644VkvSmpOtEAG4LUm8JrIBmb2DQBJ5+PW9bsp6AzHax8v4y+5DfBawrvADvgDWxJmNkvSscCpeE3qSUlnAVvhD1WbUjWAnYH/mNmK5PdLQHszu0DSL/Hz9T8p6GRxXQYB083stSTdx4BBZnaepN/jL4qrS9TYHihsWcwCPjKzyyWdC/wUrzWWSifgzaQWamY2H3geeF7SV/FWYamtqC8D38bv3e0AAR8B/wa64AauVPYGJprZLwEkTQV+JOllYOtENw164vfxAkmtzew9vDI2XtJpeAXqyBI1BgFTzWyupPnAbDO7FkDSqcBp+DUqhU+AmZK64C3O6Wb2WKLxDl4ZuHx9Eq40Q9Ae2FjSD4DjgLsL9i3Cu1jSYCbwIzO7GVb1f/fEu1Z+hXdHlIQkmdmLki4Hrks0Ngb+Zma/LTX9hH8Be0k6AliI13aeS/Z9gLdK0qA9sFGZr8urwO6S9gZmA0fgXUPg0WzTqK1PAvaR9H28W/DLwMPJvg2AkrrqCvgnsD9+L90raRawDNgSb+1MSEHjfeD7ZvYHgGSsYyfcCF0KjE1BYxv8PkJSWzN7WNKOeE1XwOQUNMDv2b0knQfcJWkmYMAWwI6svg9KoR3wbPJ9NnBNwb6N8HdCSZjZS5KeA36HG5Wuks4E3gC+CDy1vmlXmiEYi9fGtwAeY/VLDbzpdm9KOn8H2ktqZ2afJjW2+QCSHsZr1qUivDb4H0lfAn4OnIN3E5AM7K5oKIEGE3dD80Iy+HwmsBy4Di8b+EvnsVIKUMBYvKa5eZL+CwX7UrkuSYtpN+AmoAqvOdWm2wNvXpeq8aqkm3GDWQVcy+qytKeEB7WOzjuSfgx8C/ge/hJ6P9ldA/wpBZmHgOqkBr3czN7FW7RI2oN0jM3/AZ0kbWBmS5Jtv8Pv4/PwMZ2SSZ6Ra/Bxpzvw7sC38MrNR8BtKcjcASxN9B6V1CZ5hgzvYv2/UgWS9H4t6VngKHxcaCBuUF8Dbl/vtCtpsBjWfEEWXCiSJuK9ZjanDJptzGxZMjjWCR/IXZZCulvi3SgzkwGxAcBLZra01LST9IcWG+BMPDx64c3tT9LQStLdyMw+rrPtB/hAW+rXJUm/Gvg83kXxQUrpVZnZooJtwrvs3k/x2vQF3jKzT5KxmmpgYaFuChobA8sKXtK123cCZta9ViXotC08L3IPqD8BZ5hZGrX1unrd8YrMshQdHjrj5/8zz7WkrwMPm9ncFHS6AB8k4wSb4w4Vs0p9DivGEEjaADgMH5R83cx+k9QQPweML9WLp0BnM+Bc4B+s2Sd9lZmdlZJGO7y2tAveN7kV7snzEHCHmX2UgkZnvAvrz8BdZjYj2V5SS6OITlt8gHsw0A3YFB/jeB4vSxov5yp8gPVzeO2pDT5A+Q8z+0ep6Sca7fDupl3xa9IJ7yJ4ArghxZfmxvh4ySC8W+Wn+ADxjsA4M3sgBY0NgBHAEPxZ+Z2kz+E12yfTejlL6ofXaDfDa+nvAC+Y2RtppJ9obI4PEl+VGGThXnCdgWfMbHYKGp3x7rLTzOzTpBX9E2AT4D4z+1sKGhvg4xj7Aotxb6eJBfu7l+L5VkleQ0PwgdUaYKik2/Aujz74ANVWKensAPwYb+I+IulDSXOAH0o6V9IXUtAYgncLPIQP1k4CpuKDlT9OyQNmV7x7oycwRtKZSVdXakYgYU/cu2YO7ml1FT6Q1xs4J6Xrsjv+YHYE5uLnrxNwoqTvJYaiVIbg3lr344O1L+LGbFPgJ8kLPA32wPuDf4Z3bTyCjw3Nwj18+qegMQQ3NrOBA5Jn5Qz8WTk9aYmWhKRB+L27Nz728F38JfczSScmL+00GIyfL/BKwPX48zkEOFdSpxQ09gB6JUZgN/w+noN3AR8lKQ2PoSG4Q8Nz+HjDHyV9BUBSH/z+Xm8qyRDsCTybeChMAdriL9Or8RriSSnpvIr3058D7GBmm+C16ueBfqy+KUthH2CSmf0jqRU8jV/Ln+HG4KgUNPoDN5rZt/EX3J7ABEk/S5qnafEF4F9m9msz+6eZPQXch49HbEU61+WLeJfZRWZ2Bd7t8ClurIfiD1mpFLsmrfGxm+0o3SullsHAc2Y2Da/UvGpmV5jZ5bhf/DdT0GjoWWmLuxSXypfx1sZ3zOy7+PWeD/wFn1fQLwUNknReTL4fhldujsMrHO1I53x1xI0meAXqv2Z2WeI19GpKGvsCj5vZzUm6PwS+L2l7fIyrJINWSYZgJ+DNgt//Z2ZLk6bhLFI6F2a2yMzuwZuetYM3nwK3mNmxZvbjFGReALpJGp701+4PvGtmi3Ef/+1T0NiXZH1UM3sen6dwFl7D/Xni3ZEG4/GB9cOTZjxm9omZvYX7YafRunkb6C6pr6T2+FjKu8kLezZ+/krl+UTj4DJeE/DzMSX5Pgf43zr70xhL2QkfTK2lHM/KJ0BnSd2SFtmOeF/3ONwgHJKCBvhY1gBJhwIH4wbuw2TM6W3cMJTKw0CNpG+xuourli6s+d5ZXzqTDEYng+vj8bkcZ+LOCaW5pppZRXzwJmj3gt9i9RjJY8BBKemo4Ptw3DNlObB/sq0qBY0q3KviH3it8LtAh2TfXcABKWgcDmyZfG9VsH07fFLWHilem9PwGvQTuAfR35Jy/AX4XArpd8ZrnH/Bu9CuAbol+x4Hhqeg0Rbvr3+iXNckSasrsHk999vDwLAUNPYGtir43argWRmfxrOCjwf9HneBfRQ3aNsn+54BDknpfO0JnI0v6vIYMLRg3+MpPve7JPftdNx1eBbuoXYNsEsK6Q/AJwq2LdjWJnkPrKx9v6x3+mmchJb8wWu4lwMdU0qvVfKibp383gHvM94wo/KMADYqQ7pKO80k3dYF33sDB+DdKN8Btk5Za5fkBdQm+V2VvLw3Syn9okY+zWtS30sFd089BdgkJZ12Rba1BS5L8VlpnZybvXHvN3Dvp0uBTuW43+roX5xWWeqkuwPuiVaWZ7GOVqfE4GxRSjoV4TUkDwI1HK+pvYNPIAI42szS8CFem/6GeC2h2kp075NP7/8B7pm0DPe4OBSfG/GAmb1aYnZrvSD2NbN7k9+13hYdLQUXuAKdHvj4yc34RLj3Cl16U9LYAO+PHoT7ck/EH55tzeyFhv53HTQ2w/vQd8ZbBHcnmt3xazItJZ0eeO35z3hL8zXzcAytLKXgecmg9rH4GNHD+GD0QDxu0tOWkhtvch8PxbuyluD96m+lkXaBRm1ZdsPL8jDeh78N8EQa93KicTTukDAODy3RD58T86Sl4C6cuJ3vzepoBQ+auw2n9qxUiiE4CvgDcGuyaTmrZxX+D1BjZlNT0NkZ74f8N95EfMsSH+xkgPU4M7uyRI3jknS+mHhejMInxczEfaN/aWb/LlHjKOBQMzs5MQrfwD2uXsdnT15iZstL0Uh0voZ7cTxI0pS2xI1XHiSu5OigSd/waXgFoAM+W/qw5O87eFnmlahxBN4V9BdWB+dbyJrXpOSwIsn5ugjvRtsa+IuZ3VWwv3Wp10XS4fgktWfxl+ZcvDtwOj4b9xdWosulpH1xw7kR3gJYgbfMVwI3m1kaE+LWVhbwsswqg8b2+DvAgNGlGk9JwxKNRfh1/xQYaWYfJfNJ9jSzP5aiUSmDxc/iA7et8BrbOLwpvQL3UEgj6BS4h8tIvPVxBT79/05JF+B9oLunoLEd7okA3mc4zcxOBn6Jl+erKWjsyuqZo8fiNahheCyTvnhNLg36AqPxF3UX4ElJN0vayXw2axq13P3xyTwn4S/mHni/8aX4Q/WlFDT2xWtpf8YHBmeZ2Ym4Z4qRzjUBb3H80sy+gxudH0l6VdL3kwHEko0zq8tyET43pQp/Ri7H/eLTKMtXgTfN7Cgz+6KZfRnvDrwBd+1Ow4sLGi5Le+ArZdKofVY2IpnpXyLDcE+xr5vZgfgs4puSfXvjHmslURGGILHIV+K1tE3N7CF8evateJ/nIylJbYfXbi/E/Xovxbsj3sY9MdIIyXAnsGlSa+9MEsPEzD7Eu2/SmFn6BeDwxP95BD7hboaZPYmfwx1S0AB3hXzD3NPqZHzC1+vAryRdndIcAgHbJF5OO+NdAovM7GW8RbBpg//dOKYDgyWNxI3MfwDMJ8MtJomnkwKfJwklYWZ3mdkQPCBfP+DPSidK63xgZ0lD8evxonlM/ZnJvjS6EBbiHkPd5TOxMbN5ZnY3PgCaliHIoixZaPQmCWYoj1JwVvL9FHzc64lSBSoi1lDSl/ampNHAHyRtgfcZjzaPoZIW/4MPGNauDTBdq8NL/AjvjigJM3td0qN4y2MJ8A15XPJFuHEbV6oG7ukwBPe26MOaETX7sro2UirP4ZPhars13pX062TbN/Ba2zsN/H9juA4fU7kSD2J2kKT38e6bzwO3lJg+eJyZrngsmxvwSUTd8W6PPqR3vn5HEq9Iq2d4P4xXBn5AOhFnf4+7CV+ET44bJp/93Q6fOHVzChr/D68onQFM0uogcIPxsYirUtAA7w4+A/esKVdZstD4C/Bucs2XJWN238NjWR2d6JRERYwR1EXS9/BwAF8C0uqCWJvmt/C5BEvWenDj0xyCv4Cq8AfpOUthgZU6GtXACjNbmvjg3wB8x9w/vtS0O5jZwnr2bYKHcC75BpXUEw+f/bKkPfEJUVW4IfpTSl0qhXodcEO9Je7i+1iaA+BZImk7/HxthruOjknjeZHHxvo63nW3GV57noOfrwdSHPzeEPdIWpCU5Zt4KzDNspRVoz5ngKQVcjHuAlvS81gRhiAZqD0Ub7I/a2aLJXUqdZCwiE433Li8DvzTSlwhrB6Nrnh3zSt4rJS0Qz40pN0Od/dMJbCZfHr/MXiY6dfxWbKpBU1rQLcLQKmDngXp9cNnc7+Md6N9IKk6DWNZR6cv3q/9Mm5cSo4pVURjCH5/3Y9XLFaqSDDAEjW2APYiOVfJtrS9xToBPc1sQvI71RhZWWkk6W6Fv1feoM57paHK1Dpp5N0QSDqQ1at1bYwvffjHZF9vfOJMyeGB16LTC5/MVtLKZHU02icatfHi++BlebJEjQ1xf/FPgaXJi0BmZon7Ylcze6YUjUTni7gRWIoP4HbAa9Dv4l12Jce7LyjLEmBJYa1KvlpYL0sW9ihB41C89r8Mb509bma/SPbtjL8o7i9Fo47O0kTniQKdfsA2ZvZgiRpH4RMJLfk8hXd7VJGMp6VQu/0CPljcATf+D+HOAp2BX1kKQfMSnROAHc3sXHl01kPx7pulwBWWrBXSAjQOxFtORvH3Sicz+2epOpUwRnAYMMPMfp64W16T1HB+jY/oV5NOnPiGdI5OdEpdorKYxoaJxlcTjZIMAd7UHITP7qyR9AbeTz8Fd5Fsk+wrla/iKzqtcqdNXEZHAIdJqjGzF+v978ZRX1lewlcKa03pA/gH4wOEv0xeBrcm1+Q8/P7qgNeuS6Uhna/g3SslGQK8m2aCecz7v+J+6/vgcwq+gw+El3rtD8PDepyFz4UYjDtsbAccIWmGpeBqi3vo1S5sczI+oH4kPrfjaEkvmdmU+v65GWkcBvy7nvfKMfgzX7IhqASvoV1JVokyjy1zIj7AuiNeA00lHnlGOllo7IMPar+Lu9Wejnvx3I3PJUhjQRLwGnTHpD8dAHOX0ftwt86dUtAoWhY85MOp+OSyUtmZJM6Lmb2Pv5QPkvvKdySlxWjWotMpJZ1dWB2g7V086OAHZlYbQK9bCho747XaRXir80oze8LMbmL13J402B3oL2kHvNJxs5lNTVpN7Ukn9lMWGg0981uwOu5USVRCi+CfeJOqdtDlDUln4CPu/fEXQxo8iwdPa4XH5imHzrOUvyw34/3Pr9VuSAZuO+BukmkZztG4V9L/SHoBnxuxBPeL3po1VylbX7Ioy/1Aq+S6y8wWSToJX/h9d/zapEEWOnfiPurgnj2Fs9R7ks75msHqZRvvYM2KxWaksJ53wt/w2b2n4/78hWscbI2PsbUEjSye+fzHGsIv1NZ1trXCuwZqUtTpSJ24JYnO94C3U9LojE/uEkkguETjuylqbIyHwii27/qUr01HvA/6Ibx2/gg+ES+tgGMbsTqGTes6+1IpC8l6y0W2H4OHvk7rXJVdp4Hr3gNfvS8NjS3x9ZtVZ/t2eNdXmudrC9wHfy98/lCt/kMtSKPsz7xZzmMNFRvFr92W+OJ+0VIanErS3hEfyKudXbok8bQ5wEocyFuL7qbAPpbCoGSSXj+8HDPxGaCfJtu3tJTmXSQau+MrLaXmUltHQ3i/7Vvm0/FXueGlXJaD8FbGK/gEucXJ9r0shYH1rHSSMZr98PDZ/yrYvhEeSbWkcAxr0d4KD6j3aIpp9sCXj1xYsG1D3HEjlZZHFhr16Kb7zOfcEJyOW9Frkxfy7vgUcwN+a2az6/PRXUed3XGPDsPjn3fCJ2Hda0ksmFLd4+RrKn8f7wueAYzBBxB7mtmPkmNKKot8UfJv412GS/CazUo8ts3vLKVAV/I1XA/BZ93OwA3n6fj5u8rM0ljoex88PEZXvAn/LH7tOwO/N59gWOo1GYYP5n2AD3rugPetj8G9RlamdL7KriP3ST8Zv94fA3+tfSnL3aI3tBKXqJR0PP6cvIgHfhyHR5vtaqs9oNJ4HgfiNeb2eAyrO221i2dHvHVYUiUgI42yP/O15H2weHeSKfn4JI9R+ABVe+A8SVulcRLxizUb+A0++/M1fIBnpKRz5LOLS7W4K/HaYGs8NvkD+AzMb0qaJumLKZTldPyGuxxfWevHeF9kX+CK5HylUXP4Ah7J8pt4XKYReAjly4CvJA9ZqXwbX1zlEnwg7wr8fq8GzkqpLMfjfdqX46Ee7sM9lboDoyVtnNL5ykLnJHxg/VL8/j0vGYgG9xgaWmL64AZsN7z7cU/cJfVq/B7+m6T9UnoeT8crYv8Pr9BcnLjygr+8D2ohGlk8805afUzN8YPPUtw3+f40MLBg36N41L40dJ4nWegk+f0AHqKhLT7It3MKGq3xAFc/JFk0BHcVPR7vJ94xpXJ8vs62wgVJPl+qRsF1GZB8f42CRW5wA3pgChpPA9sl36cBg+tc+5LLgrtS7lzwe1xtukk5BpaqkZUOPmjbpeD3SNzRonYOQcnjNrjr8UjciNUuQvM8Pk50ahr3cJLmC3XKMgqfrQw+IP7FFqJR9me+9pN3r6F2+GLuR+Hr375VsG8TVq9LUCp/BG6TdF/yuw0eK36pfE3RkoOOmdlySc/hngJnSfp/uGfC/1l6sz7PxRcPn4DfcK+Z2X/lYSZ6sWbMoVK4Gvi1pDl4t1BvVi+11501vVXWF+EzlsGvT2Gcp01Y815YX64CbpL0OMmkNVZ7imyHhyROgyx05uCum7OTcbTbJW2Nu9r2JokJVQrmcXIexCPNjpT0O9xT6M9mtqDh/14nFgPbJvdXKzO7TFIXSdfj56vksmShkdEzv0ostx+8j3t/fObiOawe1e+BD7alpbMR3hVxLT5JZudke0/gqZQ0CpeLPBrv855eW3NISaM1PjvyGrxW8yjeJfEU8K0Uz9cGeKynU5Mb+y78xfwGcF5KGh3hs6uq4Qbt9RTLcTT+or6ZpIaIB067L+XzVVYd3LuuY+G9hrcGrsXXhUhDo3BZzR/jLZvX0jpPBWlvU3COqpK/bXF31bTKkoVG2Z/52k+uB4vrQ77Yym7mC2WXU2dDoLeVPruwNr1VXlCStsSbhk8W845KQWsDfGB1MbCxmaXVeqpPb0s8UNcblnIQuDo6XfFr/7cyamyAD4C+sdaDm7mOPJ7O5y2FkB9F0v4c3kV0l1JYVKcRer2Bvc0nr7UIjaye+dwaAkkj8PCsM/Gm8wt4f9sy87jnqQS6kgcCOxP35rgI7/Puhce2eSQNHUlnAnPM7E5JVXjYhO6429rfS8l/gcYIvAxv4wPfz+ODukstWbIyJZ1t8NZZP/ya/NaSFdXkk6XaWInupAXXZA98bYhX8G6PVdekVJJynIvPgJ6Ie1W9nuzbAD9vJT9cWegk99c7ZnZH4nI7CG81z7ckFlMKHml98bGAIcDP8GuyHV57Tq1CVnAf/xcPJzIJd4ldntZzn5FG2Z/5NfRybAjuxV/It+E129b4OrKv4U2se6xgxmkJOvcBj+Mvz+PxZTA/xePQP4YHUCstRKx0Dx7C+q+SvoEPFH2Eu0b+Hbg4hZdn4fnagjXP1zPA3ZbOcot34Q/Ov/GVl6qA883XIhiNR1d8qESN2msyCw/YVXhNas9XqddkbeV4zlKYO5KFTj3314f4i+cx0jlfxa7JEnz84e/4c1JytN4snvuMNMr+zK9Bmv1MzemDDxRfhy8KMgh/CczAPRYuxCd8pKHzHNA5+f4hq71hNsD72HunoPFPvKYM/mDumHyvTm6KNDSyOl+TKJiBjXukXF5QtjS8ebK4JmUvR4bnq777q12K91fZr0lBnst6H2ekUfZnfg29NBNrbh98IPL7yWdTfDByI3wewWcGEtcj/Q2Bycn3VnjXUOGA2BS8f70UjWrcn3g6PjHqI6BdmhoZnq9qvDtoS9YcCPsHPs/jGYqEUWim16Ss5cjwfJX9/srimmR5H5dbI8tnvvaT266hWpIBlrNwK76XmaW1UD1J311PM5tRt09QPvX8ATPbub7/XwedjfCJOENwb5gLzcNX9MBjmqQRqbNWq5znqw3et1pj7pba2txFrhP+ctvMzLYsUaPs1ySLcmSsU9b7K6vnpI5m2e7jLDSyfOYhx2MEdZF0Nr7k4tXl9lCQx2wZAPQxs1vLpCG8SbqLJQNUKaefyfnS6thPn8cn+P2yTDplvSYZliMrnbLeX4lGFs9J2e/jDJ+Vsl2TXBoCSXvjU7Pn4ou6v4Z7kCw2s8kN/e966ryH93u+gcdOmWtmk1LyStobn3QzD28izsCn+881szQmxjTF+XoXL0vt+ZpnZhMltTWzpSlplPualLUcWelkfH+V7ZrU0SnbfZyhRlmvSV3yOrP4Gnxm6dN4f9ubePyPe+S+/dMsnZmMdXXewOOy/F/i2jcNKHU90bVpvJpCWbI8X63wCWp1y9IWdyks9QWa1TUpdzmy0mmK+6sc16SYTjnu46bQKMc1WYO8Bp2rXQv3E9zFay4+YNUdD9q1QZl05uGDRd3xmZPtMtBIoyxZnq8l1F+W6pQ0srgm5S5HVjpNcX+V45oU0ynHfdwUGuW4JmuS5shzc/rg/rbnAsclv/+d/N2ypenkRSNPZYnz1fw08lSWrM5X7SeXYwS1yBd7/ireBXaAmaUR3rhJdPKikZVOXjSy0smLRlY6edGoJa9dQ8CqxZ7PxZvQtVO/27REnbxoZKWTF42sdPKikZVOXjRqyV2LQL44+cF43PN2+IDLQ3jTalGKHgpl18mLRlY6edHISicvGlnp5EWjqG4ODcFf8WBQj+Excz6PB+yqAc61Epfby1InLxpZ6eRFIyudvGhkpZMXjaKUY+ChKT94cK6qItu/jq/m1L6l6ORFI09lifPV/DTyVJaszlfdT67GCCRthvskH1tk9xh8mvtHLUEnLxpZ6eRFIyudvGhkpZMXjXq1E2uTG+Rxzy8BuuEz8l7AZ2bujwdqGtlSdPKikZVOXjSy0smLRlY6edEoqpsnQyDpy/hCES8C++D9a7sCK/Al5P5uZp+0BJ28aGSlkxeNrHTyopGVTl406qUc/U1N9QHuB4bnQScvGnkqS5yv5qeRp7Jkdb6KfXI1RoDHbS/rOrEZ6uRFIyudvGhkpZMXjax08qJRlNx0DSUBn+bjizl8iq9V/ArwEvCymf2npejkRSMrnbxoZKWTF42sdPKi0RB5ij7aF1/e7WA8LGyfZNs3gG0lzTezoS1EJy8aWenkRSMrnbxoZKWTF416yZMh2BGYYr6g81PJBwBJ7fHofS1FJy8aWenkRSMrnbxoZKWTF416yZMh+AR4EkDJKk61O8x9b9Pyv81CJy8aWenkRSMrnbxoZKWTF416ydNg8XZAH0mdzZfyawUgaUtJacWHz0onLxpZ6eRFIyudvGhkpZMXjfppClelcnzwqdmbFtn+ZeByYJOWopMXjTyVJc5X89PIU1myOl/16pcz8aw+wFb4yDoknlB19k8rtr056uRFI09lifPV/DTyVJaszldDn7x0DXUCZknaxMxMUquCptX2wIeWnNEWoJMXjax08qKRlU5eNLLSyYtGg+TFELwOTAZulNTBzFaa2UpJvYATgFdbkE5eNLLSyYtGVjp50chKJy8aDdLiJ5RJvlBDYkEvwxd+/hB4GV9U+r/AVWb2dnPXyYtGnsoS56v5aeSpLFmdr7Xmo6UbAgBJOwPzzOxdSZsC/YDeuF/u5JakkxeNrHTyopGVTl40stLJi8Za85ATQ3AtYMDHePS+t/AVfd4DFpnZhy1FJy8aWenkRSMrnbxoZKWTF4215qGlGwJJbYGDCyVjCgAAA2JJREFUgE3wQZdOwHKgDfA5oMbMTmkJOnnRyEonLxpZ6eRFIyudvGg0hhY/s9jMluLhWwGQ1B0YBQzCo/mtbCk6edHISicvGlnp5EUjK528aDSGPLQItgK2B7oC38M9oR4BFgMPmlkqI+5Z6ORFIyudvGhkpZMXjax08qLRKKyMkxSy+AC341bz73jgptYtVScvGnkqS5yv5qeRp7Jkdb7W9slDi2BfYC/gAGB3fLDlTWAi7ps71syWtwSdvGhkpZMXjax08qKRlU5eNBqVj5ZuCOoiaSNgW2AgPgjzPTP7uCXq5EUjK528aGSlkxeNrHTyolFUN2+GIAiCIFg38hJiIgiCIFhPwhAEQRBUOGEIglwhqaOkKcnnHUmzCn63rXPsOPkygA2lVyOpQ5Htm0j6vaT/SHpF0hOSdk+7PInWt5LZp3W3t5a0sByaQWXR4ieUBUEhZvY+MABA0kX4FP2rCo+RJHx8bHgJUjfhUSF3MDOTtAPQq4T0gqDJiBZBUBFI2kHSvyT9FngR2Lqwti/pb5ImJbX7b60lrT64sbnQEm8LM5thZg/Vl1ZSe79F0tQkH6cn23slLZNJkp6S1Hst2ttLel7SBOCi0s5KEDjRIggqib7AyWZ2KoA3DFZxopnNl7QhMFHSvWa2oJ50dgYmm1l90/8/kxYeTbKTme2SaNd2N90IfMvM/iNpL+B63G2wPq4DfmVmt0k6Y+1FDoK1E4YgqCT+Y2YT6tn3Q0kjku/d8Gn/E9dTp1haM/DFyX8FPAg8khiDIcC9BUZpbc/knvg6tgC3AD9bzzwGwSrCEASVRNGJOZIOBPYFhpjZYkn/ANo1kM4rwABJreq2CupLy8zel9QfOAQ4HTgK+Ckeh37AOpTBkk8QpEaMEQQBbArMT17cO+NT/evFzKYDU4ELkoFnJPWR9OX60pLUGR+gvhu4ENgt6XqaI+mI5JhWknZdS16fA76WfD9ufQobBHUJQxAE8ACwoaSXgAuA5xvxPycD3YEZkv4F/BaY3UBa3YGnJE0Bfg+cm2w/Bjg1Of4V4NC16J6Odz29AGzcyPIFQYNEiIkgCIIKJ1oEQRAEFU4YgiAIggonDEEQBEGFE4YgCIKgwglDEARBUOGEIQiCIKhwwhAEQRBUOGEIgiAIKpz/D91SU2Bv2ooRAAAAAElFTkSuQmCC\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Available p-value trials plot with success cutoff\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Rank</th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funded Bys</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>p-values</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>13</td>\n",
       "      <td>NCT04392141</td>\n",
       "      <td>Colchicine Plus Phenolic Monoterpenes to Treat...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Standard Treatment|Drug: Oral administra...</td>\n",
       "      <td>Mortality Rate|SpO2|Length of Hospitalization|...</td>\n",
       "      <td>All</td>\n",
       "      <td>10 Years and older   (Child, Adult, Older Adult)</td>\n",
       "      <td>Phase 1|Phase 2</td>\n",
       "      <td>120</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>1-Apr-20</td>\n",
       "      <td>1-Nov-20</td>\n",
       "      <td>18-May-20</td>\n",
       "      <td>Islamic Republic of</td>\n",
       "      <td>3.180000e-02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>34</td>\n",
       "      <td>NCT04542694</td>\n",
       "      <td>Study of Favipiravir Compared to Standard of C...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Favipiravir|Drug: Standard of care</td>\n",
       "      <td>Rate of Clinical Status Improvement|Time to Cl...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 80 Years   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>200</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>21-May-20</td>\n",
       "      <td>20-Aug-20</td>\n",
       "      <td>9-Sep-20</td>\n",
       "      <td>Russian Federation</td>\n",
       "      <td>3.720000e-02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>36</td>\n",
       "      <td>NCT04401579</td>\n",
       "      <td>Adaptive COVID-19 Treatment Trial 2 (ACTT-2)</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Other: Placebo|Drug: Remdesivir|Drug: Baricitinib</td>\n",
       "      <td>Time to Recovery|Change From Baseline in Alani...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 99 Years   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>1033</td>\n",
       "      <td>NIH</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>8-May-20</td>\n",
       "      <td>31-Jul-20</td>\n",
       "      <td>26-May-20</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>4.700000e-02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>37</td>\n",
       "      <td>NCT04280705</td>\n",
       "      <td>Adaptive COVID-19 Treatment Trial (ACTT)</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Other: Placebo|Drug: Remdesivir</td>\n",
       "      <td>Time to Recovery|Change From Baseline in Alani...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 99 Years   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>1062</td>\n",
       "      <td>NIH</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>21-Feb-20</td>\n",
       "      <td>21-May-20</td>\n",
       "      <td>21-Feb-20</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>1.000000e-03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123</th>\n",
       "      <td>124</td>\n",
       "      <td>NCT04292730</td>\n",
       "      <td>Study to Evaluate the Safety and Antiviral Act...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Remdesivir|Drug: Standard of Care</td>\n",
       "      <td>Part A: Percentage of Participants in Each Cli...</td>\n",
       "      <td>All</td>\n",
       "      <td>12 Years and older   (Child, Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>1113</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>15-Mar-20</td>\n",
       "      <td>26-Jun-20</td>\n",
       "      <td>3-Mar-20</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>1.740000e-02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>274</th>\n",
       "      <td>275</td>\n",
       "      <td>NCT04523831</td>\n",
       "      <td>Clinical Trial of Ivermectin Plus Doxycycline ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Covid19</td>\n",
       "      <td>Drug: Ivermectin and Doxycycline|Drug: Standar...</td>\n",
       "      <td>Number of Patients With Early Clinical Improve...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>400</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>1-Jun-20</td>\n",
       "      <td>10-Sep-20</td>\n",
       "      <td>24-Aug-20</td>\n",
       "      <td>Bangladesh</td>\n",
       "      <td>1.000000e-03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>292</th>\n",
       "      <td>293</td>\n",
       "      <td>NCT04343092</td>\n",
       "      <td>Effectiveness of Ivermectin as add-on Therapy ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>COVID 19</td>\n",
       "      <td>Drug: Ivermectin (IVM)</td>\n",
       "      <td>Number of Cured Patients|Time to Cure of COVID...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>16</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>18-Apr-20</td>\n",
       "      <td>1-Jun-20</td>\n",
       "      <td>13-Apr-20</td>\n",
       "      <td>Iraq</td>\n",
       "      <td>5.000000e-02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>355</th>\n",
       "      <td>356</td>\n",
       "      <td>NCT04425850</td>\n",
       "      <td>USEFULNESS of Topic Ivermectin and Carrageenan...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Covid19</td>\n",
       "      <td>Combination Product: Iota carrageenan nasal sp...</td>\n",
       "      <td>Number of Infected Subjects|Adverse Events Oth...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>229</td>\n",
       "      <td>Other</td>\n",
       "      <td>Observational</td>\n",
       "      <td>1-Jun-20</td>\n",
       "      <td>10-Aug-20</td>\n",
       "      <td>11-Jun-20</td>\n",
       "      <td>Argentina</td>\n",
       "      <td>1.000000e-04</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>905</th>\n",
       "      <td>906</td>\n",
       "      <td>NCT04425863</td>\n",
       "      <td>Ivermectin, Aspirin, Dexamethasone and Enoxapa...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Severe Acute Respiratory Syndrome|Ventilation ...</td>\n",
       "      <td>Drug: Ivermectin 5 MG/ML oral solution, Aspiri...</td>\n",
       "      <td>Patients Who Improved Their Condition or Did N...</td>\n",
       "      <td>All</td>\n",
       "      <td>5 Years and older   (Child, Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>167</td>\n",
       "      <td>Other</td>\n",
       "      <td>Observational</td>\n",
       "      <td>1-May-20</td>\n",
       "      <td>30-Aug-20</td>\n",
       "      <td>11-Jun-20</td>\n",
       "      <td>Argentina</td>\n",
       "      <td>2.460000e-02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>932</th>\n",
       "      <td>933</td>\n",
       "      <td>NCT04542226</td>\n",
       "      <td>Observational Open Study of Polyoxidonium in H...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Infections, Coronavirus</td>\n",
       "      <td>Drug: Polyoxidonium</td>\n",
       "      <td>Clinical Status of the Patient (According to 7...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>81</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Observational</td>\n",
       "      <td>31-Mar-20</td>\n",
       "      <td>30-Oct-20</td>\n",
       "      <td>9-Sep-20</td>\n",
       "      <td>Russian Federation</td>\n",
       "      <td>1.000000e-07</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     Rank   NCT Number                                              Title  \\\n",
       "12     13  NCT04392141  Colchicine Plus Phenolic Monoterpenes to Treat...   \n",
       "33     34  NCT04542694  Study of Favipiravir Compared to Standard of C...   \n",
       "35     36  NCT04401579       Adaptive COVID-19 Treatment Trial 2 (ACTT-2)   \n",
       "36     37  NCT04280705           Adaptive COVID-19 Treatment Trial (ACTT)   \n",
       "123   124  NCT04292730  Study to Evaluate the Safety and Antiviral Act...   \n",
       "274   275  NCT04523831  Clinical Trial of Ivermectin Plus Doxycycline ...   \n",
       "292   293  NCT04343092  Effectiveness of Ivermectin as add-on Therapy ...   \n",
       "355   356  NCT04425850  USEFULNESS of Topic Ivermectin and Carrageenan...   \n",
       "905   906  NCT04425863  Ivermectin, Aspirin, Dexamethasone and Enoxapa...   \n",
       "932   933  NCT04542226  Observational Open Study of Polyoxidonium in H...   \n",
       "\n",
       "        Status Study Results  \\\n",
       "12   Completed   Has Results   \n",
       "33   Completed   Has Results   \n",
       "35   Completed   Has Results   \n",
       "36   Completed   Has Results   \n",
       "123  Completed   Has Results   \n",
       "274  Completed   Has Results   \n",
       "292  Completed   Has Results   \n",
       "355  Completed   Has Results   \n",
       "905  Completed   Has Results   \n",
       "932  Completed   Has Results   \n",
       "\n",
       "                                            Conditions  \\\n",
       "12                                            COVID-19   \n",
       "33                                            COVID-19   \n",
       "35                                            COVID-19   \n",
       "36                                            COVID-19   \n",
       "123                                           COVID-19   \n",
       "274                                            Covid19   \n",
       "292                                           COVID 19   \n",
       "355                                            Covid19   \n",
       "905  Severe Acute Respiratory Syndrome|Ventilation ...   \n",
       "932                            Infections, Coronavirus   \n",
       "\n",
       "                                         Interventions  \\\n",
       "12   Drug: Standard Treatment|Drug: Oral administra...   \n",
       "33            Drug: Favipiravir|Drug: Standard of care   \n",
       "35   Other: Placebo|Drug: Remdesivir|Drug: Baricitinib   \n",
       "36                     Other: Placebo|Drug: Remdesivir   \n",
       "123            Drug: Remdesivir|Drug: Standard of Care   \n",
       "274  Drug: Ivermectin and Doxycycline|Drug: Standar...   \n",
       "292                             Drug: Ivermectin (IVM)   \n",
       "355  Combination Product: Iota carrageenan nasal sp...   \n",
       "905  Drug: Ivermectin 5 MG/ML oral solution, Aspiri...   \n",
       "932                                Drug: Polyoxidonium   \n",
       "\n",
       "                                      Outcome Measures Gender  \\\n",
       "12   Mortality Rate|SpO2|Length of Hospitalization|...    All   \n",
       "33   Rate of Clinical Status Improvement|Time to Cl...    All   \n",
       "35   Time to Recovery|Change From Baseline in Alani...    All   \n",
       "36   Time to Recovery|Change From Baseline in Alani...    All   \n",
       "123  Part A: Percentage of Participants in Each Cli...    All   \n",
       "274  Number of Patients With Early Clinical Improve...    All   \n",
       "292  Number of Cured Patients|Time to Cure of COVID...    All   \n",
       "355  Number of Infected Subjects|Adverse Events Oth...    All   \n",
       "905  Patients Who Improved Their Condition or Did N...    All   \n",
       "932  Clinical Status of the Patient (According to 7...    All   \n",
       "\n",
       "                                                  Age           Phases  \\\n",
       "12   10 Years and older   (Child, Adult, Older Adult)  Phase 1|Phase 2   \n",
       "33        18 Years to 80 Years   (Adult, Older Adult)          Phase 3   \n",
       "35        18 Years to 99 Years   (Adult, Older Adult)          Phase 3   \n",
       "36        18 Years to 99 Years   (Adult, Older Adult)          Phase 3   \n",
       "123  12 Years and older   (Child, Adult, Older Adult)          Phase 3   \n",
       "274         18 Years and older   (Adult, Older Adult)          Phase 3   \n",
       "292         18 Years and older   (Adult, Older Adult)          Phase 1   \n",
       "355         18 Years and older   (Adult, Older Adult)              NaN   \n",
       "905   5 Years and older   (Child, Adult, Older Adult)              NaN   \n",
       "932         18 Years and older   (Adult, Older Adult)              NaN   \n",
       "\n",
       "     Enrollment Funded Bys      Study Type Start Date Completion Date  \\\n",
       "12          120      Other  Interventional   1-Apr-20        1-Nov-20   \n",
       "33          200      Other  Interventional  21-May-20       20-Aug-20   \n",
       "35         1033        NIH  Interventional   8-May-20       31-Jul-20   \n",
       "36         1062        NIH  Interventional  21-Feb-20       21-May-20   \n",
       "123        1113   Industry  Interventional  15-Mar-20       26-Jun-20   \n",
       "274         400      Other  Interventional   1-Jun-20       10-Sep-20   \n",
       "292          16      Other  Interventional  18-Apr-20        1-Jun-20   \n",
       "355         229      Other   Observational   1-Jun-20       10-Aug-20   \n",
       "905         167      Other   Observational   1-May-20       30-Aug-20   \n",
       "932          81   Industry   Observational  31-Mar-20       30-Oct-20   \n",
       "\n",
       "    First Posted             Locations      p-values  \n",
       "12     18-May-20   Islamic Republic of  3.180000e-02  \n",
       "33      9-Sep-20    Russian Federation  3.720000e-02  \n",
       "35     26-May-20        United Kingdom  4.700000e-02  \n",
       "36     21-Feb-20        United Kingdom  1.000000e-03  \n",
       "123     3-Mar-20        United Kingdom  1.740000e-02  \n",
       "274    24-Aug-20            Bangladesh  1.000000e-03  \n",
       "292    13-Apr-20                  Iraq  5.000000e-02  \n",
       "355    11-Jun-20             Argentina  1.000000e-04  \n",
       "905    11-Jun-20             Argentina  2.460000e-02  \n",
       "932     9-Sep-20    Russian Federation  1.000000e-07  "
      ]
     },
     "execution_count": 85,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Available p-value trials plot with success cutoff \n",
    "pvalues = covid_df['p-values'].map(lambda x: str(x)).map(lambda x: x.replace('<','')).map(lambda x: float(x))\n",
    "mapped_df = covid_df.copy(deep=True)\n",
    "mapped_df['p-values'] = pvalues\n",
    "mapped_df = mapped_df.dropna(subset=['p-values'])\n",
    "x_axis_vals = range(1, pvalues.count() + 1)\n",
    "cutoff = [0.05] * 13\n",
    "xlabels = mapped_df['NCT Number']\n",
    "plt.scatter(x_axis, mapped_df['p-values'])\n",
    "plt.plot(x_axis, cutoff, 'r', label='Success cutoff (0.05)')\n",
    "plt.xticks(np.arange(1,14), xlabels, rotation=80)\n",
    "plt.title(\"Available p-values\")\n",
    "plt.xlabel(\"Trial Case Id\")\n",
    "plt.ylabel(\"p-value\")\n",
    "plt.legend(loc=\"upper right\")\n",
    "plt.show()\n",
    "success_df = mapped_df[mapped_df['p-values'] <= 0.05]\n",
    "print(\"Available p-value trials plot with success cutoff\")\n",
    "success_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
